Polymerase chain reaction and blood culture in blood donors screened by ELISA test for Chagas' disease by Kinoshita-Yanaga, Andréa Tieko et al.
*Correspondence: M. L. Gomes. Laboratório de Doença de Chagas, De-
partamento de Ciências Básicas da Saúde, Universidade Estadual de Mar-
ingá. Av. Colombo, 5790 - Zona Sete - 87020-900 - Maringá - PR, Brazil. 
E-mail: mlgomes@uem.br
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 47, n. 1, jan./mar., 2011
Polymerase chain reaction and blood culture in blood donors 
screened by ELISA test for Chagas’ disease
Andréa Tieko Kinoshita-Yanaga1, Marta Bértoli2, Vanessa Aparecida Martins1, Angélica Sayuri 
Mizutani1, Max Jean de Ornelas Toledo1, Silvana Marques de Araújo1, Mônica Lúcia Gomes1,*
1Chagas’Disease Laboratory, Department of Basic Health Sciences, State University of Maringá, 
2Regional Blood Donation Center of Maringá, State University of Maringá
The objective of this study was to evaluate, through blood culture and PCR, the results of the ELISA 
for Chagas’ disease in the screening of blood donors in the public blood-supply network of the state of 
Paraná, Brazil, and to map the epidemiological profile of the donors with respect to their risk of infection 
by Trypanosoma cruzi. The negative and positive results of the ELISA were confirmed by blood culture 
and PCR for 190/191 individuals (99.5%). For one individual (0.5%), the ELISA was inconclusive, blood 
culture and IIF were negative, and IHA and PCR positive. Three individuals (1.6%) were positive for 
T. cruzi on all the tests. Donors were predominantly female, and natives of Paraná, of rural origin, had 
observed or been informed of the presence of the vector in the municipalities where they resided, had never 
received a blood transfusion, had donated blood 1 to 4 times, and reported no cases of Chagas’ disease 
in their families. We concluded that PCR and blood culturing have excellent potential for confirming the 
results of the ELISA, and that candidate blood donors with negative or positive tests have a similar risk 
of infection by T. cruzi, indicating that the ELISA test is sufficiently safe for screening blood prior to use.
Uniterms: Trypanosoma cruzi/detection. ELISA/use for screening. Blood donors. Blood culture. PCR. 
Blood bank/screened donors.
O objetivo deste estudo foi avaliar, pela hemocultura e PCR, os resultados do teste ELISA utilizado 
para doença de Chagas na triagem de doadores de sangue na rede pública do Estado do Paraná, Brasil, 
e traçar o perfil epidemiológico dos doadores quanto ao risco de infecção pelo Trypanosoma cruzi. Os 
resultados negativos e positivos do ELISA foram confirmados pela hemocultura e PCR em 190/191 
indivíduos (99,5%). Para um indivíduo (0,5%), o teste de ELISA foi inconclusivo, hemocultura e IFI 
foram negativas, HAI e PCR foram positivas. Três indivíduos (1,6%) foram positivos para T. cruzi em 
todos os testes. A maioria dos doadores era do sexo feminino, oriundos do Estado do Paraná, de origem 
rural, tinham observado ou foram informados da presença do vetor nos municípios onde residiam, 
nunca tinham recebido sangue, haviam doado sangue de 1 a 4 vezes e não relataram casos de doença de 
Chagas na família. Nós concluímos que a PCR e a hemocultura são excelentes testes para confirmar os 
resultados do ELISA e os candidatos a doadores de sangue com testes positivos e negativos apresentam 
risco semelhante de infecção pelo T. cruzi, reforçando o nível satisfatório de segurança do teste ELISA 
para liberar o sangue para o uso.
Unitermos: Trypanosoma cruzi/detecção. ELISA/uso para triagem. Sangue/doadores. Hemocultura. 
PCR. Banco de Sangue/triagem de doadores.
INTRODUCTION
The Ministry of Health of Brazil, through the 
National Health Monitoring Agency, approved reso-
lution RDC No. 153 (Brasil, 2004) in June 2004. This 
resolution mandates that a highly sensitive immunoen-
zyme test for Chagas’ disease must be used to screen 
blood bags prior to their release, in accordance with 
recommendations of the World Health Organization 
(WHO, 2002).
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The risk of transmission of Trypanosoma cruzi 
through transfusion of a single, 500-mL unit of whole 
blood ranges from 12% to 20% (WHO, 2002). In Brazil, 
the seroprevalence of Chagas’ disease in the public blood-
bank network is 0.6% whereas the seroprevalence rate in 
private blood banks is unknown (Silveira et al., 2002). 
The serological tests (indirect immunofluorescence or IIF, 
indirect hemagglutination or IHA, and immunoenzyme or 
ELISA) used to diagnose Chagas’ disease generally have 
sensitivity of 95% and specificity of 93 to 98%, indicating 
that no one test is sufficiently sensitive to totally eliminate 
the risk of transmission of T. cruzi through blood trans-
fusion (Salles et al., 1996; Oelemann et al., 1998; Saez-
Alquezar et al., 1998).
Other techniques capable of verifying the presence 
of T. cruzi in infected patients include blood culture, xe-
nodiagnosis, and PCR. Several investigators (Avila et al., 
1993; Wincker et al., 1994; Gomes et al., 1999; Castro et 
al., 2002; Salomone et al., 2003; Vera-Cruz et al., 2003; 
Batista et al., 2007) have reported that individuals with 
negative or inconclusive serology on the IIF and ELISA 
tests had positive results on xenodiagnosis, blood culture, 
or PCR. Some of these scholars (Castro et al., 2002) did 
not rule out the possibility that the frequency of individu-
als who are serologically negative and have an active T. 
cruzi infection detected only by PCR, may be higher than 
previously thought. Other authors (Salomone et al., 2003), 
having demonstrated the presence of T. cruzi by PCR in in-
dividuals that showed no serological evidence for Chagas’ 
disease, believe that their findings challenge the present re-
commendations for Chagas’ disease diagnosis, treatment, 
and monitoring of blood transfusions. Vera-Cruz et al. 
(2003), in a study comparing PCR with the commercially 
available ELISA test on samples collected in an endemic 
area in Mexico, found a higher positive rate using PCR 
than on ELISA. Based on these results, the authors raised 
the possibility that the ELISA method underestimates the 
prevalence of T. cruzi infections.
The genetic diversity of T. cruzi can also influence 
the performance of serological tests. Mice inoculated with 
parasites of the T. cruzi II group (referred to as Discrete Ty-
ping Units - DTU II by Zingales et al., 2009) showed rates 
of positivity with ELISA ranging from 83.3% to 93.3%, 
blood culture from 60.6% to 76.7%, and PCR 100%. For 
mice inoculated with parasites of the T. cruzi group I (DTU 
I by Zingales et al., 2009), the positivity of the ELISA and 
PCR were both 100%, whereas that of the blood culture 
ranged from 89.5% to 90.2% (Miyamoto et al., 2006).
The Chagas’ Disease Laboratory of the State Uni-
versity of Maringá, as part of its mission to improve the 
care of patients with this disease, established the program 
“Chagas’ Disease Awareness through Comprehensive 
Education” (Araújo et al., 2000). In order to expand this 
program and devise new action strategies, it is important to 
define the profile of the patients treated by this laboratory, 
including candidate blood donors.
Based on these considerations, the objective of this 
study was to confirm, by means of blood culture and PCR, 
the results of the ELISA for Chagas’ disease obtained du-
ring the screening of candidate blood donors in the public 
blood-supply network of Paraná, and to map the epide-
miological profile of the population studied, with respect 
to the risk of their being infected by T. cruzi.
MATERIALS AND METHODS
Population studied
From March 2007 through February 2008, a period 
in which the Maringá Regional Blood Donation Center 
(Hemocentro Regional de Maringá - HRM) in Paraná 
processed a total of 9358 candidate blood donors, 191 
blood samples were collected from individuals of 16 
municipalities belonging to the 15th Health Region of the 
State of Paraná (Figure 1). The collection routine of the 
HRM was maintained, and the sample was representati-
ve of the regional population. The criteria for inclusion 
of individuals in the study were the screening doctor’s 
authorization to collect an additional volume of blood, 
and donor age, such that the same numbers of individuals 
for the age ranges 18 to 33, 34 to 49, and 50 to 65 years 
could be obtained. The sample size (n) was calculated 
using the formula n = Nn0 / (N+n0), where n0 = p (1-p) 
(z0.05/e)
2, and N is the size of the population (considering 
the number of candidate blood donors of each age group 
predicted for the 12-month period). The p value refers 
to the occurrence of the event investigated, based on the 
mean of the preceding three years for Chagas’ disease in 
the HRM (0.28); z0.05 corresponds to the 95% percentage 
of the standard normal distribution, and to the maximum 
sampling error of 10% (0.1). The minimum sample size 
resulting from this calculation was 188, with a 90% 
confidence level.
Individuals who were clinically qualified to donate 
blood were informed of the purpose of the study, and sig-
ned a consent form approved by the Committee for Ethi-
cal Research on Human Beings of UEM. ELISA, blood 
culture, and PCR tests were done on the blood samples 
collected. Each prospective donor was interviewed by 
means of a specific questionnaire collecting data on items 
that could indicate a risk of infection by T. cruzi, including 
native state or country, rural or urban origins, original hou-
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sing structure, presence of the vector in the municipality, 
present housing structure, rural laborer status, previous 
blood transfusion, previous blood donation, and presence 
of Chagas’ disease in the family.
ELISA
The ELISA reaction to detect anti-T. cruzi IgG an-
tibodies was performed with the ELISA III® Chagas Test 
diagnostic kit (BiosChile Ingenharia Genética S.A., Chile) 
made available by the Public Blood-Supply Network of 
Paraná, and applied according to the recommendations 
of the manufacturer. Whenever a sample was reactive or 
inconclusive in the initial test, the test was repeated in 
duplicate, using blood from the same sample.
Blood culture
To carry out this test, 30 mL of blood was collected 
in heparinized tubes. The blood cultures were then proces-
sed in LIT medium and incubated at 28 °C, according to 
Chiari et al. (1989) with modifications. The samples were 
homogenized once a week, and examined 30, 60, 90, and 
120 days after processing.
PCR
For each individual, 10 mL of blood was added to 
an equal volume of 6 M Guanidine-HCl/0.2 M EDTA 
(Sigma Chemical Company, USA), pH 8.0. Using 200 mL 
of blood, the DNA was extracted with phenol-chloroform 
and precipitated in absolute ethanol in the presence of 
100 mM sodium acetate (Gomes et al., 1998). DNA was first 
resuspended in 20 mL of sterile deionized water. After 24 
to 36 hours stored at 4 °C, the DNA was washed with 70% 
ethanol, precipitated, and resuspended in 10 mL of water.
The PCR was processed by mixing 2 mL of the DNA 
solution from each sample, together with 10 mM Tris-HCl 
(pH 9.0), 0.1% Triton X-100, 75 mM KCl, 3.5 mM MgCl2 
, 0.2 mM of each deoxynucleotide (dATP, dCTP, dGTP, 
dTTP, Invitrogen Ltda.), 0.5 U of Taq DNA polymerase 
(Invitrogen), and 10 pmoles of each primer for 10 mL of 
reaction.
 Primers 121 (5’AAATAATGTACGGG(T/G)GA-
GATGCATGA3’) and 122 (5’GGTTCGATTGGGGT-
TGGTGTAATATA 3’) were used as described by Wincker 
et al. (1994); these primers amplify fragments of a variable 
330 bp region of the T. cruzi kDNA minicircle. The DNA 
was next amplified in an automatic thermocycler (MJ Re-
FIGURE 1 - Municipalities of origin of candidate blood donors studied, Paraná State, Brazil. Note: values in parentheses represent 
number of candidate blood donors from each municipality.
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search, PTC-150) with denaturing at 95 °C for 1 min (with 
a longer initial step, for 5 min), annealing of the primers 
at 65 °C for 1 min, and extension at 72 °C for 1 min (with 
a 10-min final step) for a total of 35 cycles (Gomes et al., 
1998). For the steps of DNA extraction and PCR, negative 
controls with blood samples from uninfected individuals 
from a non-endemic area, and positive controls of indi-
viduals with Chagas’ disease were used. The products 
amplified by the PCR were observed by electrophoresis 
in 4% polyacrylamide gel and by silver staining (Santos, 
Pena, Epplen, 1993).
IIF and IHA
The tests described were carried out on those 
samples that were positive on ELISA, blood culture, or 
PCR tests. The IIF and IHA were executed with reagents 
manufactured by BioMérieux Brasil SA, according to the 
recommendations of the manufacturer. Anti-T. cruzi anti-
bodies of the IgG class were investigated; a titer ≥ 40 was 
considered reactive for IIF. For the IHA, the qualitative 
test was carried out according to the positive and negative 
sera of the HRM and of the Laboratory for Teaching and 
Research on Clinical Analyses (Laboratório de Ensino e 
Pesquisa em Análises Clínicas - LEPAC) of UEM. The de-
monstrably positive cases were sent to the ACHEI program 
(Araújo et al., 2000), to which the patients were referred 
for medical care, with etiological treatment and follow up 
every six months for at least five years.
RESULTS
Of the 191 candidate blood donors who underwent 
serological screening for Chagas’ disease, 188 tested nega-
tive on ELISA. Two individuals were positive on the ELI-
SA, IIF, and the IHA whereas 1 person had inconclusive 
results on the ELISA, testing negative on IIF and positive 
on IHA. On the blood cultures, 189 individuals presented 
negative, and 2 positive results. For the PCR, a total of 
188 individuals tested negative and 3 positive (Table I). 
The results of the ELISA were confirmed by blood 
culture and PCR for 190 individuals (99.5%). In one case 
(0.5%), the ELISA was inconclusive, blood culture was 
negative, and PCR positive. Of the three cases in which 
the ELISA was positive or inconclusive, two were shown 
to be positive by blood culture, and three by PCR (Table I).
Table II shows that the epidemiological profile of 
the population studied for risk of infection by T. cruzi was 
similar for subjects with negative (188) and positive (3) 
tests. The majority of the individuals investigated were 
natives of states where Chagas’ disease is endemic and had 
lived in rural areas, both constituting risk factors associa-
ted with this disease. Also, the sample was predominantly 
female and the majority reported no history of Chagas’ 
disease in the family. The three individuals with positive 
results on at least one of the tests were 48 years of age or 
older, presently residing in municipalities in Paraná (Co-
lorado, Sarandi, and Floresta), were rural laborers, while 
two reported having had a case of Chagas’ disease in the 
family, also considered a risk factor for Chagas’ disease.
DISCUSSION
The HRM is a unit of intermediate complexity with 
macroregional responsibility, and provides support and 
assistance to the health network, supervises services, and 
performs serological examinations for all the collection 
units. It is a reference center for Northwestern Paraná, a 
region endemic for Chagas’ disease. After the resolution 
of the Ministry of Health came into effect in 2004 (Brasil, 
2004), the HRM began to use only the ELISA test to screen 
blood donors for Chagas’ disease.
In the present study, the results of the ELISA 
were confirmed by blood culture and PCR in a high 
percentage of samples, affirming the use of ELISA as 
the sole test for screening prospective blood donors. 
Satisfactory results for different ELISA kits have been 
previously reported (Oelemann et al., 1998; Leiby et 
al., 2000; Blejer, Saguier, Salamone, 2001; Gadelha 
et al., 2003; Pirard et al., 2005). However, the results 
TABLE I - Results of tests performed on candidate blood donors at the Maringá Regional Blood Donation Center, Paraná, Brazil, 
from March 2007 through February 2008
No. Individuals ELISA Blood culture PCR IIF IHA Positive (%)
188 N N N NT NT 0.0
2 P P P P P 1.1
1 I N P N P 0.5
Total 191 1.6
No. = Number; % = Percentage; P = Positive; N = Negative; I = Inconclusive; NT = Not tested.
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TABLE II - Epidemiological characteristics and positive tests for Trypanosoma cruzi among candidate blood donors at the Maringá 
Regional Blood Donation Center, Paraná, Brazil, from March 2007 through February 2008
Epidemiological 
characteristics
n (%) Positive tests*
Gender
Female 
Male
99 (51.8)
92 (48.2)
2†
1‡
Native state or country
Paraná
São Paulo
Minas Gerais
Mato Grosso do Sul
Mato Grosso
Alagoas
Bahia
Rio Grande do Sul
Pernambuco
Sergipe
Ceará
Japan
133 (69.7)
31 (16.3)
8 (4.2)
4 (2.1)
3 (1.6)
3 (1.6)
2 (1.0)
2 (1.0)
2 (1.0)
1 (0.5)
1 (0.5)
1 (0.5)
1†
1‡
1†
0
0
0
0
0
0
0
0
0
Area
Rural
Urban
110 (57.6)
81 (42.4)
3† ‡
0
Original housing structure
Wood
Concrete block with plaster
Wattle and daub
Unplastered concrete block
Mixed
Not known
130 (68.1)
29 (15.2)
17 (8.9)
0 (0.0)
0 (0.0)
15 (7.8)
1†
0
2† ‡
0
0
0
Epidemiological 
characteristics
n (%) Positive tests*
Presence of the vector in the 
municipality
Yes
No
109 (57.1)
82 (42.9)
2†
1‡
Present housing
Concrete block with plaster
Wood
Unplastered concrete block
Wattle and daub
Mixed
163 (85.3)
27 (14.2)
1 (0.5)
0 (0.0)
0 (0.0)
3† ‡
0
0
0
0
Rural laborer
Yes
No
128 (67.0)
63 (33.0)
3† ‡
0
Blood transfusion
No
Yes
177 (92.7)
14 (7.3)
3† ‡
0
Previous blood donations
1 to 4 times
Never
5 to 10
More than 10
71 (37.2)
54 (28.3)
42 (22.0)
24 (12.5)
1†
2† ‡
0
0
Chagas’ disease in the family
No
Yes
Not known
169 (88.5)
20 (10.5)
2 (1.0)
1†
2† ‡
0
Total 191 (100.0) 3† ‡
n = Number; % = Percentage; * Candidate blood donors with positive results for Trypanosoma cruzi infection. † Elisa, Blood 
culture, PCR, IIF, and IHA positive. ‡ Elisa inconclusive, Blood culture and IIF negative, PCR and IHA positive.
presented in this study must be interpreted cautiously by 
considering the samples analyzed, the serological tests 
and reagents, the technical procedures, quality control, 
and the protocols for extraction and amplification of the 
DNA, and taking into account that the study area has a 
low prevalence of Chagas’ disease. Although high levels 
of agreement, principally between serological and mo-
lecular tests, in diagnosing Chagas’ disease have been 
reported (Avila et al., 1993; Britto et al., 1995; Junquei-
ra, Chiari, Wincker, 1996; Gomes et al., 1999; Castro et 
al., 2002; Marcon et al., 2002; Salomone et al., 2003; 
Vera-Cruz et al., 2003; Coronado et al., 2006), positi-
ve results on xenodiagnosis, blood culture or PCR, in 
conjunction with negative or inconclusive serological 
tests, have also been demonstrated (Avila et al., 1993; 
Gomes et al., 1999; Castro et al., 2002; Marcon et al., 
2002; Salomone et al., 2003; Vera-Cruz et al., 2003). 
As a result of this lack of agreement, Salomone et al. 
(2003) and Vera-Cruz et al. (2003) raised the question 
as to whether a single serological test to screen blood 
bags for release is safe, and whether the ELISA test 
underestimates the prevalence of T. cruzi infections.
In the present study, positivity for T. cruzi was 1.6% 
(3/191) for all the tests used. This positivity rate is very 
similar to that reported by the regional blood donation 
centers of Londrina/Paraná, Brazil (Oliveira-Marques et 
al., 2005) and Iguatu/Ceará, Brazil (Sobreira et al., 2001), 
reflecting the success of the program to eliminate Triato-
ma infestans and of the regular and rigorous screening of 
donors at blood banks in place since the 1980s (Franco-
Paredes, Bottazzi, Hotez, 2009; Fernandes et al., 2009; 
Villela et al., 2009). Monteon et al. (2005) and Hernández-
Becerril et al. (2005) also observed low seroprevalence 
(1.24% and 0.37%, respectively) in candidate blood 
donors in Mexico. However, the positivity rate observed 
in the present study is high compared to the data presented 
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by Schmunis and Cruz (2005), Sabino et al. (2003), Silva 
et al. (2007) and Araújo, Vianna, Berne (2008). 
For two cases in which the ELISA was positive, the 
blood culture was also positive. In the one case which was 
inconclusive on ELISA, the blood culture was negative. 
These are very good results, because in the samples for 
which the ELISA was positive, the blood culture, a test 
known for its low sensitivity (Chiari et al., 1989; Gomes 
et al., 1998; Castro et al., 2002), also showed a positive 
result. This good performance of the blood culture may 
be related to the level of parasitemia of the individuals at 
the time of donation, and to the quality of execution of 
this technique in our laboratory, given it is laborious and 
requires aseptic procedures and good-quality reagents.
As mentioned, the ELISA was inconclusive in one 
individual, yet even in this case the protocol proposed by 
the Ministry of Health enabled elimination of the sample 
collected, since it was positive for IHA, despite testing 
negative on the IIF. In addition, the PCR result was posi-
tive, indicating that the PCR technique could be a valid 
alternative if reference centers using this methodology are 
established. Other investigators have also shown that, in 
individuals with inconclusive serology, tests such as the 
PCR and the TESA-Blot can be used to confirm the results 
(Umezawa et al., 1996; Gomes et al., 1999; Marcon et al., 
2002; Silveira-Lacerda et al., 2004; Batista et al., 2007; 
Araújo, Vianna, Berne, 2008). Although Duarte et al. 
(2006) observed sensitivity rates of 95.7 to 100% for IIF, 
IHA, and ELISA, and 1.2% for PCR, several investigators 
have reported good agreement of IIF and ELISA results 
with those of the PCR (Britto et al., 1995; Junqueira, 
Chiari, Wincker, 1996; Gomes et al., 1999; Hernández-
Becerril et al., 2005; Coronado et al., 2006), in-line with 
the results of the present study.
Of the conventional serological tests used to diag-
nose Chagas’ disease, the IHA has the lowest sensitivity 
(Oelemann et al., 1998; Leiby et al., 2000; Blejer, Saguier, 
Salamone, 2001; Gadelha et al., 2003; Pirard et al., 2005). 
However, in the present study, the IHA was able to con-
firm the diagnosis of one individual with an inconclusive 
ELISA and a negative IIF result. This result corroborates 
the concerns of several investigators (Blejer, Saguier, 
Salamone, 2001; Gadelha et al., 2003; Pirard et al., 2005; 
Araújo, Vianna, Berne, 2008) who have emphasized the 
importance of combining several effective tests when 
screening for Chagas’ disease at the blood banks, thereby 
reducing false-negative or inconclusive results and cross-
reactions (Saéz-Alquezar et al., 1998). 
In the present study, the inclusion of two other sero-
logical tests (IIF and IHA) was only required to confirm 
the diagnosis in 3 individuals with positive results on at 
least one of the tests applied (ELISA, blood culture or 
PCR), considering that the results of these three tests with 
different principles were concordant for most of the indivi-
duals investigated. As recommended by Luquetti (1990), 
confirmation of the diagnosis of individuals suspected of 
harboring T. cruzi infection screened in the blood-supply 
network and/or that have positive results on other tests, 
requires high sensitivity and specificity, made possible by 
combining two techniques (IIF and IHA).
According to Gontijo, Rocha, Oliveira (1996), risk 
factors for Chagas’ disease include being born in a rural 
area, living in states endemic for Chagas’ disease, and 
having a history of Chagas’ disease in the family. Using 
these criteria, candidate blood donors in the present study 
all had a similar risk of infection by T. cruzi. Our results 
reinforce the effectiveness of serological screening and 
the good performance of the ELISA test, which whilst 
not perfect, provide a satisfactory level of safety for blood 
screening. Other evidence that demonstrated the discrimi-
natory power of the ELISA was the three individuals with 
positive or inconclusive results on this test who, in addition 
to exhibiting risk factors associated with Chagas’ disease, 
reported other important epidemiological characteristics 
such as presence of the vector in the municipalities of 
residence, and rural laborer status. With respect to age, 
all the individuals who were positive for infection were 
48 years of age or older, a finding which may reflect the 
success of the Brazilian program to eliminate T. infestans, 
the principal domestic vector of T. cruzi. 
Determining the profile of individuals living in areas 
of low prevalence, as achieved in the present study, yields 
important information that can be applied in areas where 
Chagas’ disease is more prevalent and also in regions 
with active infection, thus allowing the groups at risk to 
be identified. Consequently, appropriate health education 
such as that carried out under the ACHEI Program (Araújo 
et al., 2000) can be developed. The ACHEI program has 
demonstrated, in practice, the benefits of psychological 
and psychosocial intervention in preventing aggravation 
of the disease, given that symptomatic patients were found 
to exhibit more physical and psychological stress, lower 
capacity for resistance (expressed as greater despair and 
emotional difficulties), and lower capacity for tenacity and 
innovation (Mota et al., 2006).
CONCLUSION
The results of this study allow us to conclude that 
blood culture and PCR have good potential for confirming 
results of the ELISA test. The data also indicate that the 
ELISA has desirable reliability for screening potential 
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blood donors at the HRM, since candidate blood donors 
with negative or positive tests showed a similar risk of in-
fection by T. cruzi. However, the possibility of conflicting 
results from analyses performed in other blood-supply 
networks using different diagnostic kits cannot be ruled 
out. Taken together, these results demonstrate that the 
blood used in transfusions in Northwestern Paraná shows a 
satisfactory level of safety. Studies at multiple centers and 
including samples from regions with a high prevalence of 
Chagas’ disease should be conducted, in order to confirm 
the observations of the present study.
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